Capstone Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
KKRC
GGHC
Capstone Asset Management's AMED Position: Q2 2017 in Review
Capstone Asset Management reduced its Amedisys (AMED) stake by 9% in Q2 2017, selling an estimated $32.6K and leaving 5,659 shares worth $355K. The position accounts for 0.01% of the portfolio, ranked #1134.
Capstone Asset Management first reported a position in AMED in Q2 2013 and has held it in 17 quarters since. The position peaked at $484K in Q3 2013. 169 funds tracked by Wall St. Rank hold AMED as of Q2 2017.
- Capstone Asset Management held 5,659 shares of Amedisys worth $355K as of Q2 2017.
- Capstone Asset Management sold 560 Amedisys shares in Q2 2017, an estimated $32.6K.
- Amedisys made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1134 holding.
- Capstone Asset Management first reported a position in Amedisys in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Amedisys position peaked at $484K in Q3 2013.
- 169 funds tracked by Wall St. Rank held Amedisys as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.